CKD-846
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
July 22, 2026
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
(clinicaltrials.gov)
- P1 | N=34 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Completed
Trial completion • Benign Prostatic Hyperplasia
February 12, 2026
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Chong Kun Dang Pharmaceutical
New P1 trial • Benign Prostatic Hyperplasia
January 15, 2026
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
(clinicaltrials.gov)
- P1 | N=31 | Completed | Sponsor: Chong Kun Dang Pharmaceutical | Recruiting ➔ Completed
Trial completion • Benign Prostatic Hyperplasia
May 23, 2024
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: Chong Kun Dang Pharmaceutical | Not yet recruiting ➔ Recruiting | Trial completion date: Aug 2024 ➔ Dec 2024
Enrollment open • Trial completion date • Benign Prostatic Hyperplasia
1 to 4
Of
4
Go to page
1